획기적 치료제 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)
Breakthrough Therapy Drug Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드 : 1818194
리서치사 : Lucintel
발행일 : 2025년 09월
페이지 정보 : 영문 150 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,850 ₩ 5,558,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,650 ₩ 6,713,000
PDF (2 Users License) help
PDF 보고서를 동일 사업장에서 2명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,350 ₩ 7,724,000
PDF (5 Users License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,050 ₩ 10,178,000
PDF (Corporate License) help
PDF 보고서를 기업 내 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 획기적 치료제 시장의 미래는 병원, 클리닉, 외래 서비스 시장에서의 기회로 유망시되고 있습니다. 세계의 획기적 치료제 시장은 2025-2031년에 CAGR 14.2%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 규제 당국의 지원과 신속한 승인, 만성질환 및 희귀질환의 유병률 증가입니다.

획기적 치료제 시장의 새로운 동향

세계 혁신 치료제 시장의 새로운 동향은 중증 질환에 대한 보다 개인화된 표적 치료제로의 전환을 반영하고 있습니다. 이러한 추세는 새로운 치료법의 개발, 승인, 환자 제공 방식에 큰 변화를 가져오고 있습니다. 기술 혁신, 규제 변화, 진화하는 시장 역학이 이 급성장하는 시장의 방향을 이끌고 있습니다.

세계 혁신 치료제 시장은 암 치료에 대한 관심 증가, 유전자 및 세포 치료의 혁신, 재생의료의 발전, AI와 ML의 역할, 임상 검사의 세계화 등 몇 가지 주요 신흥 동향에 의해 형성되고 있습니다. 이러한 추세는 획기적인 신약 개발을 가속화할 뿐만 아니라, 치료를 보다 개인화하여 전 세계 환자들이 보다 쉽게 이용할 수 있도록 하고 있습니다. 기술 발전, 규제 당국의 지원, 진화하는 환자들의 요구가 결합하여 획기적인 치료제를 발견, 개발, 제공하는 방식에 큰 변화를 가져올 수 있는 발판이 마련되고 있습니다.

획기적 치료제 시장의 최근 동향

최근 획기적인 치료제 시장 동향은 기술 혁신의 빠른 속도와 새로운 치료법에 대한 수요 증가를 반영하고 있습니다. 제약사, 정부, 규제 당국은 획기적인 치료법 개발을 촉진하는 환경 조성에 점점 더 많은 노력을 기울이고 있습니다. 이러한 발전은 생명을 위협하는 심각한 질병을 치료하는 데 있으며, 협력, 규제 당국의 지원, 기술 발전의 중요성을 강조하고 있습니다.

FDA의 획기적 치료제 지정 확대, 면역종양학, 유전자 편집 기술, 희귀질환 치료제 개발, 전략적 제휴 등 세계 획기적 치료제 시장의 주요 개발은 의약품 개발의 판도를 바꾸고 있습니다. 이러한 발전은 보다 신속한 승인, 보다 표적화된 치료, 그리고 생명을 구할 수 있는 치료법에 대한 환자의 접근성 확대로 이어지고 있습니다. 생명공학, 유전체학, 면역치료의 혁신이 계속 가속화됨에 따라 향후 수년간 시장이 더욱 형성되어 전 세계 환자들에게 희망을 가져다주고 의약품 혁신의 새로운 기준을 세우게 될 것으로 예측됩니다.

목차

제1장 개요

제2장 시장 개요

제3장 시장 동향과 예측 분석

제4장 세계의 획기적 치료제 시장(유형별)

제5장 세계의 획기적 치료제 시장(용도별)

제6장 지역 분석

제7장 북미의 획기적 치료제 시장

제8장 유럽의 획기적 치료제 시장

제9장 아시아태평양의 획기적 치료제 시장

제10장 기타 지역의 획기적 치료제 시장

제11장 경쟁 분석

제12장 기회와 전략 분석

제13장 밸류체인 전체에 걸친 주요 기업의 기업 개요

제14장 부록

KSA
영문 목차

영문목차

The future of the global breakthrough therapy drug market looks promising with opportunities in the hospitals, clinics and ambulatory services markets. The global breakthrough therapy drug market is expected to grow with a CAGR of 14.2% from 2025 to 2031. The major drivers for this market are the regulatory support & fast-track approval and the rising prevalence of chronic & rare diseases.

Emerging Trends in the Breakthrough Therapy Drug Market

Emerging trends in the global breakthrough therapy drug market reflect the shift toward more personalized, targeted treatments for serious diseases. These trends are reshaping how new therapies are developed, approved, and delivered to patients. Technological innovations, regulatory changes, and evolving market dynamics are driving the direction of this fast-growing market.

The global breakthrough therapy drug market is being shaped by several key emerging trends, including a growing focus on oncology treatments, innovations in gene and cell therapies, advances in regenerative medicine, the role of AI and ML, and the globalization of clinical trials. These trends are not only accelerating the development of breakthrough drugs but are also making treatments more personalized and accessible to patients worldwide. The convergence of technological advancements, regulatory support, and evolving patient needs is setting the stage for significant transformation in the way breakthrough therapies are discovered, developed, and delivered.

Recent Developments in the Breakthrough Therapy Drug Market

Recent developments in the breakthrough therapy drug market reflect the rapid pace of innovation and the growing demand for novel treatments. Pharmaceutical companies, governments, and regulatory agencies are increasingly focused on fostering environments that accelerate the development of groundbreaking therapies. These developments highlight the importance of collaboration, regulatory support, and advancements in technology to overcome challenges in treating serious and life-threatening diseases.

Key developments in the global breakthrough therapy drug market, including the expansion of FDA breakthrough designations, advancements in immuno-oncology, gene editing technologies, rare disease drug development, and strategic partnerships, are transforming the landscape of drug development. These developments are leading to faster approvals, more targeted therapies, and greater patient access to life-saving treatments. The continued acceleration of breakthroughs in biotechnology, genomics, and immunotherapies will further shape the market in the years to come, offering hope for patients worldwide and setting new standards for pharmaceutical innovation.

Strategic Growth Opportunities in the Breakthrough Therapy Drug Market

The global Breakthrough Therapy Drug market represents a rapidly expanding and evolving sector in the pharmaceutical industry. Breakthrough therapy designation, granted by regulatory agencies like the U.S. FDA, is designed to expedite the development and review of drugs that show significant potential in treating serious or life-threatening conditions. This designation offers companies advantages such as faster regulatory approval, accelerated clinical trials, and market exclusivity, which can lead to lucrative opportunities.

The global breakthrough therapy drug market presents several strategic growth opportunities across key applications, including personalized treatments, immuno-oncology, gene therapies, and rare disease treatments. By capitalizing on advancements in AI, gene editing, and partnerships with research institutions, pharmaceutical companies can accelerate the development of innovative therapies. Emerging markets and collaborations also provide valuable opportunities for growth. As regulatory bodies continue to streamline approval processes, the market for breakthrough therapies is poised for significant expansion, with new and groundbreaking treatments making a real impact on patient outcomes worldwide.

Breakthrough Therapy Drug Market Driver and Challenges

The global breakthrough therapy drug market is influenced by several key drivers, including technological advancements, regulatory support, and a growing focus on precision medicine. However, challenges related to cost, regulatory complexity, and market access remain critical factors that could impact the pace of growth. Understanding these drivers and challenges is essential for navigating the dynamic landscape of breakthrough therapy drug development.

The factors responsible for driving the breakthrough therapy drug market include:

1. Regulatory Accelerations: Regulatory bodies worldwide are increasingly prioritizing breakthrough therapies, fast-tracking approval processes for drugs that show significant potential in treating serious conditions. This has led to quicker access to novel therapies for patients, especially in critical areas such as oncology and rare diseases.

2. Technological Advancements: Advancements in gene editing, immuno-oncology, and biotechnology are providing new ways to treat complex diseases. These innovations are creating exciting possibilities for breakthrough therapies, particularly in areas where traditional treatments have been ineffective.

3. Increased Funding for R&D: Government and private sector investments in pharmaceutical R&D are driving the development of breakthrough therapies. Increased funding allows for more extensive clinical trials, faster development timelines, and access to cutting-edge technologies, enabling quicker market entry for innovative drugs.

4. Growing Patient Demand: Patients and healthcare providers are increasingly demanding new treatments for serious and life-threatening diseases. The demand for breakthrough therapies is particularly high in oncology, rare diseases, and chronic conditions, driving pharmaceutical companies to prioritize the development of novel therapies.

5. Personalized Medicine: The growing shift toward personalized medicine, which tailors treatments to individual genetic profiles, is driving the market for breakthrough therapies. Advances in genomics and biomarkers are allowing for more precise and effective treatments, particularly in cancer and rare diseases.

Challenges in the breakthrough therapy drug market are:

1. High Development Costs: The costs of developing breakthrough therapies, particularly gene therapies and biologics, are often prohibitively high. These costs can limit access to these therapies for patients, particularly in emerging markets.

2. Regulatory Hurdles: Although regulatory bodies offer fast-tracking for breakthrough therapies, navigating complex approval processes remains a challenge. In some regions, regulatory frameworks are still evolving, making it difficult to gain approval for innovative therapies.

3. Market Access and Affordability: Even with regulatory approval, gaining market access and ensuring the affordability of breakthrough therapies remain significant challenges. High prices, limited insurance coverage, and lack of healthcare infrastructure in certain regions can hinder patient access to these life-changing treatments

The drivers of the global breakthrough therapy drug market include regulatory acceleration, technological advancements, increased funding for R&D, growing patient demand, and the shift toward personalized medicine. However, challenges such as high development costs, regulatory hurdles, and issues related to market access and affordability persist. By addressing these challenges while leveraging the market drivers, pharmaceutical companies can expand their presence in the growing breakthrough therapy drug market and improve patient outcomes.

List of Breakthrough Therapy Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breakthrough therapy drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breakthrough therapy drug companies profiled in this report include-

Breakthrough Therapy Drug Market by Segment

The study includes a forecast for the global breakthrough therapy drug market by type, application, and region.

Breakthrough Therapy Drug Market by Type [Value from 2019 to 2031]:

Breakthrough Therapy Drug Market by Application [Value from 2019 to 2031]:

Breakthrough Therapy Drug Market by Region [Value from 2019 to 2031]:

Country Wise Outlook for the Breakthrough Therapy Drug Market

The global breakthrough therapy drug market has experienced significant developments in recent years, spurred by advancements in biotechnology, a growing focus on precision medicine, and increasing regulatory support. Breakthrough therapy designation (BTD) by regulatory bodies like the FDA accelerates the development and review of drugs that show substantial improvement over existing therapies for serious or life-threatening conditions. The US, China, Germany, India, and Japan have become key players in this market, with major pharmaceutical companies driving research and development (R&D) to create life-changing treatments. These countries are embracing innovative approaches to accelerate drug approval and bring new therapies to market faster.

Features of the Global Breakthrough Therapy Drug Market

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Trends & Forecast Analysis

4. Global Breakthrough Therapy Drug Market by Type

5. Global Breakthrough Therapy Drug Market by Application

6. Regional Analysis

7. North American Breakthrough Therapy Drug Market

8. European Breakthrough Therapy Drug Market

9. APAC Breakthrough Therapy Drug Market

10. ROW Breakthrough Therapy Drug Market

11. Competitor Analysis

12. Opportunities & Strategic Analysis

13. Company Profiles of the Leading Players Across the Value Chain

14. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기